CelluPep Retatrutide research peptide vial
Control del peso

Retatrutide Research Peptide

Retatrutide for research use, with batch documentation and selected formats available from our US warehouse. Contact CelluPep for specifications, availability and B2B supply.

Target purity>99%
Specifications5mg × 10 vials
SupplyCatalog and bulk inquiry
DocumentsBatch-specific on request
Available specifications5mg × 10 vials · 10mg × 10 vials · 15mg × 10 vials · +6 more
View all specifications

Final availability and analytical results are confirmed for the supplied batch.

Product overview

Retatrutida is supplied for metabolic signaling and energy-balance research. The catalog identity is Retatrutida; order-specific purity, composition and net content are confirmed against the applicable Certificate of Analysis.

Available formats include 5mg × 10 vials, 10mg × 10 vials, 15mg × 10 vials, 20mg × 10 vials, 30mg × 10 vials, 40mg × 10 vials, 50mg × 10 vials, 60mg × 10 vials, 100mg × 10 vials. CelluPep supports qualified laboratory, biotechnology and distribution inquiries with specification review, batch documentation and coordinated global fulfillment.

For research use only. Not for human consumption, diagnostic use or therapeutic use.

Product identification

Reference identity information supports product evaluation. Batch-specific test results remain subject to the documentation supplied with each order.

Chemical identity

Product name
Retatrutida
CAS number
Available on request
Molecular formula
Available on request
Molecular weight
Available on request

Research form

Peptide type
Research-grade reference material
Research category
Control del peso
Appearance
Per project specification
Supplied form
Per project

Reference identity: Retatrutide. Confirm order-specific identity and analytical results against the supplied batch documentation.

Available specifications

CelluPep supports catalog and bulk Retatrutide inquiries. Final availability is confirmed after the requested quantity, purity and packaging requirements are reviewed.

Purity options
>99%
Cantidad
5mg × 10 vials · 10mg × 10 vials · 15mg × 10 vials · 20mg × 10 vials · 30mg × 10 vials · 40mg × 10 vials · 50mg × 10 vials · 60mg × 10 vials · 100mg × 10 vials
Packaging
5mg × 10 vials
Labeling
Standard, private-label and OEM requirements
Minimum order
Confirmed according to specification and packaging
Lead time
Confirmed with current batch or production availability
Request current availability

Quality documentation

Document availability is confirmed for the requested specification and production batch. Ask the sales team which analytical files are available before placing an order.

Batch-specific COAProduct identity, batch reference and available quality results are organized for document review.
HPLC analysisPurity information for the relevant batch
MS analysisIdentity information for the relevant batch
Learn about quality control

Manufacturing and supply process

Each inquiry is reviewed against the requested product specification, quantity, documentation and destination.

  1. Share requirementsSend the target quantity, purity, packaging and destination.
  2. Confirm specificationOur team reviews availability, documentation and lead time.
  3. Prepare supplyPackaging and labeling are matched to the confirmed order.
  4. Arrange shipmentShipping options are confirmed for the destination market.
View manufacturing capabilities

Packaging, storage and shipping

Standard vial supply, custom labeling, OEM packaging and bulk quantities can be discussed with the CelluPep team.

Packaging

Sealed research vials with specification-dependent labeling and packing options.

Storage

Storage and handling conditions are confirmed in the project specification and batch documentation.

Shipping

Lead time and shipping arrangements depend on quantity, specification and destination.

Retatrutide supply questions

What Retatrutide specifications are available?

Availability depends on the requested quantity, purity and packaging format. Send your requirements for current specification confirmation.

Can I request a batch-specific COA?

Yes. Ask the sales team to confirm the documentation available for the relevant specification and batch.

Does CelluPep support bulk Retatrutide inquiries?

Bulk requirements can be reviewed for qualified laboratory, biotechnology and distribution customers.

Is custom vial labeling available?

Custom labeling, private-label and OEM packaging requirements can be discussed during quotation.

What information is needed for a quotation?

Please provide the product name, target quantity, preferred specification, packaging requirements and shipping destination.

Is this product intended for human use?

No. This page describes material supplied for research use only. It is not offered for human consumption, diagnosis or therapeutic use.

Technical and supply resources

Page owner: CelluPep Product and Quality Team. Updated September 5, 2026.

Related literature

Selected peer-reviewed studies for scientific context and further reading.

  1. Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.

    Jastreboff AM, Kaplan LM, Frías JP, Wu Q, Du Y, Gurbuz S, Coskun T, Haupt A, Milicevic Z, Hartman ML, Retatrutide Phase 2 Obesity Trial Investigators.

    The New England journal of medicine. 2023. doi:10.1056/nejmoa2301972. PMID:37366315
    View source
  2. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.

    Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, Coskun T.

    Lancet (London, England). 2023. doi:10.1016/s0140-6736(23)01053-x. PMID:37385280
    View source
  3. Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial.

    Sanyal AJ, Kaplan LM, Frias JP, Brouwers B, Wu Q, Thomas MK, Harris C, Schloot NC, Du Y, Mather KJ, Haupt A, Hartman ML.

    Nature medicine. 2024. doi:10.1038/s41591-024-03018-2. PMID:38858523
    View source

References are provided for general scientific context. They do not describe or validate a specific CelluPep batch and are not medical guidance.

LET’S TALK

Leave us a message

Tell us what you need. Our team will get back to you by email.

Chat on WhatsApp